FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129487968> ?p ?o ?g. }

• W2129487968 endingPage "26" @default.
• W2129487968 startingPage "16" @default.
• W2129487968 abstract "Abstract Src is a nonreceptor tyrosine kinase involved in the cross-talk and mediation of many signaling pathways that promote cell proliferation, adhesion, invasion, migration, and tumorigenesis. Increased Src activity has been reported in many types of human cancer, including gastric cancer. Therefore, this factor has been identified as a promising therapeutic target for cancer treatments, and targeting Src in gastric cancer is predicted to have potent effects. We evaluated the antitumor effect of a c-Src/Abl kinase inhibitor, saracatinib (AZD0530), alone or combined with chemotherapeutic agents in gastric cancer cell lines and a NCI-N87 xenograft model. Among 10 gastric cancer cell lines, saracatinib specifically inhibited the growth and migration/invasion of SNU216 and NCI-N87 cells. Saracatinib blocked the Src/FAK, HER family, and oncogenic signaling pathways, and it induced G1 arrest and apoptosis in SNU216 and NCI-N87 cells. Apoptosis required induction of the proapoptotic BCL2 family member Bim. Knockdown of Bim using siRNA decreased apoptosis induced by treatment with saracatinib, suggesting that Bim has an important role in saracatinib-induced apoptosis. Saracatinib enhanced the effects of lapatinib, an EGFR/HER2 dual inhibitor, in SNU216 and NCI-N87 cells. Furthermore, combined treatment with saracatinib and 5-fluorouracil (5-FU) or cisplatin exerted synergistic effects in both saracatinib-sensitive and saracatinib-resistant cells. Consistent with our in vitro findings, cotreatment with saracatinib and 5-FU resulted in enhanced antitumor activity in the NCI-N87 xenografts. These data indicate that the inhibition of Src kinase activity by saracatinib alone or in combination with other agents can be a strategy to target gastric cancer. Mol Cancer Ther; 12(1); 16–26. ©2013 AACR." @default.
• W2129487968 created "2016-06-24" @default.
• W2129487968 creator A5009933828 @default.
• W2129487968 creator A5036241941 @default.
• W2129487968 creator A5040764520 @default.
• W2129487968 creator A5050684671 @default.
• W2129487968 creator A5051090454 @default.
• W2129487968 creator A5052823826 @default.
• W2129487968 creator A5059766169 @default.
• W2129487968 creator A5064057011 @default.
• W2129487968 creator A5069050806 @default.
• W2129487968 creator A5080983203 @default.
• W2129487968 creator A5086634668 @default.
• W2129487968 date "2013-01-01" @default.
• W2129487968 modified "2023-10-05" @default.
• W2129487968 title "Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer" @default.
• W2129487968 cites W1964230131 @default.
• W2129487968 cites W1969572743 @default.
• W2129487968 cites W1974019160 @default.
• W2129487968 cites W1988698939 @default.
• W2129487968 cites W1990915902 @default.
• W2129487968 cites W1992954790 @default.
• W2129487968 cites W1996552531 @default.
• W2129487968 cites W1999868376 @default.
• W2129487968 cites W2002790722 @default.
• W2129487968 cites W2011017763 @default.
• W2129487968 cites W2012750775 @default.
• W2129487968 cites W2026279585 @default.
• W2129487968 cites W2032775411 @default.
• W2129487968 cites W2033997665 @default.
• W2129487968 cites W2044858733 @default.
• W2129487968 cites W2065486105 @default.
• W2129487968 cites W2066003961 @default.
• W2129487968 cites W2068326740 @default.
• W2129487968 cites W2068333274 @default.
• W2129487968 cites W2077945404 @default.
• W2129487968 cites W2092343827 @default.
• W2129487968 cites W2098613950 @default.
• W2129487968 cites W2100626226 @default.
• W2129487968 cites W2101257013 @default.
• W2129487968 cites W2102088611 @default.
• W2129487968 cites W2109462974 @default.
• W2129487968 cites W2112463023 @default.
• W2129487968 cites W2113615565 @default.
• W2129487968 cites W2115533799 @default.
• W2129487968 cites W2143799421 @default.
• W2129487968 cites W2144398239 @default.
• W2129487968 cites W2147000598 @default.
• W2129487968 cites W2150310014 @default.
• W2129487968 cites W2150891833 @default.
• W2129487968 cites W2158971458 @default.
• W2129487968 cites W2160318185 @default.
• W2129487968 doi "https://doi.org/10.1158/1535-7163.mct-12-0109" @default.
• W2129487968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23144237" @default.
• W2129487968 hasPublicationYear "2013" @default.
• W2129487968 type Work @default.
• W2129487968 sameAs 2129487968 @default.
• W2129487968 citedByCount "55" @default.
• W2129487968 countsByYear W21294879682013 @default.
• W2129487968 countsByYear W21294879682014 @default.
• W2129487968 countsByYear W21294879682015 @default.
• W2129487968 countsByYear W21294879682016 @default.
• W2129487968 countsByYear W21294879682017 @default.
• W2129487968 countsByYear W21294879682018 @default.
• W2129487968 countsByYear W21294879682019 @default.
• W2129487968 countsByYear W21294879682020 @default.
• W2129487968 countsByYear W21294879682021 @default.
• W2129487968 countsByYear W21294879682022 @default.
• W2129487968 countsByYear W21294879682023 @default.
• W2129487968 crossrefType "journal-article" @default.
• W2129487968 hasAuthorship W2129487968A5009933828 @default.
• W2129487968 hasAuthorship W2129487968A5036241941 @default.
• W2129487968 hasAuthorship W2129487968A5040764520 @default.
• W2129487968 hasAuthorship W2129487968A5050684671 @default.
• W2129487968 hasAuthorship W2129487968A5051090454 @default.
• W2129487968 hasAuthorship W2129487968A5052823826 @default.
• W2129487968 hasAuthorship W2129487968A5059766169 @default.
• W2129487968 hasAuthorship W2129487968A5064057011 @default.
• W2129487968 hasAuthorship W2129487968A5069050806 @default.
• W2129487968 hasAuthorship W2129487968A5080983203 @default.
• W2129487968 hasAuthorship W2129487968A5086634668 @default.
• W2129487968 hasBestOaLocation W21294879681 @default.
• W2129487968 hasConcept C108636557 @default.
• W2129487968 hasConcept C121608353 @default.
• W2129487968 hasConcept C126322002 @default.
• W2129487968 hasConcept C170493617 @default.
• W2129487968 hasConcept C190283241 @default.
• W2129487968 hasConcept C42362537 @default.
• W2129487968 hasConcept C502942594 @default.
• W2129487968 hasConcept C55493867 @default.
• W2129487968 hasConcept C555283112 @default.
• W2129487968 hasConcept C71924100 @default.
• W2129487968 hasConcept C86803240 @default.
• W2129487968 hasConcept C96232424 @default.
• W2129487968 hasConceptScore W2129487968C108636557 @default.
• W2129487968 hasConceptScore W2129487968C121608353 @default.
• W2129487968 hasConceptScore W2129487968C126322002 @default.
• W2129487968 hasConceptScore W2129487968C170493617 @default.

• next